Tepnel buys Orchid Biosciences

That was always a good one, lending a director money to buy shares in the comapny - I actually thought that was against FSA guidelines, but nothing was done.

As for the pathetic share price, it is a consequence of poor management and poor corporate governance. If you are confidant that these matters will be forgiven, and that the management will finally deliver, then invest away, I am out, and will stay out until nearer the time the price is measured to decide how many free shares they get, around which time I am convinced the corporate communication team will have gone into overdrive to tell everyone about anything and everything the company does.

Time will tell, but form a financial point, this was not one of my better investment decisions.